Literature DB >> 6326885

Interactions of cannabinoids with bovine serum albumin.

S J Haque, M K Poddar.   

Abstract

There is no shift of emission maximum (F470nm) of bovine serum albumin (BSA)-1-anilino-8-naphthalene sulphonic acid (ANS) complex in the presence of delta-9-tetrahydrocannabinol (delta-9-THC) alone and cannabidiol (CBD) or cannabinol (CBN) in the presence and absence of delta-9-THC. Delta-9-THC (1.66-13.33 microM) and CBD at higher concentrations (13.33-20.0 microM) produce a concentration-dependent significant quenching of fluorescence of BSA-ANS complex, but CBN (1.66-20.0 microM) as well as CBD at lower concentrations (1.66-6.66 microM) fails to produce any significant change in fluorescence intensity under similar conditions. Furthermore, neither CBD nor CBN is able to affect the delta-9-THC-induced quenching of fluorescence intensity of BSA-ANS complex. These results indicate that the binding of cannabinoids to the ANS binding sites of BSA molecule are in the order delta-9-THC greater than CBD greater than CBN, and CBD or CBN does not have any influence on the binding of delta-9-THC to BSA molecules under these conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326885     DOI: 10.1007/bf01119659

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  3 in total

1.  Studies on the interaction of tricyclazole with beta-cyclodextrin and human serum albumin by spectroscopy.

Authors:  Hua-Xin Zhang; Xing Huang; Ping Mei; Ke-Hua Li; Cheng-Nong Yan
Journal:  J Fluoresc       Date:  2006-05-16       Impact factor: 2.217

2.  Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin.

Authors:  D Shcharbin; B Klajnert; V Mazhul; M Bryszewska
Journal:  J Fluoresc       Date:  2005-01       Impact factor: 2.217

3.  Regarding the Mechanisms of Promiscuous Cannabinoid Pharmacology: An Elephant Has Entered the Room.

Authors:  Peter S Cogan
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.